Waters Investor
Waters Division creates business advantages for laboratory-dependent organizations by delivering ultra-performance liquid chromatography (UPLC), high-performance liquid chromatography (HPLC), chromatography columns and chemistry products, mass spectrometry systems, laboratory informatics solutions, and comprehensive service programs to enable significant advancement in healthcare delivery, environmental management, food safety, and water quality.
Technology:
Predictive Toxicology and ADMET Modeling
Funding Status:
public
Investor Type:
Venture Funds
Industry:
BioPharma AI
Headquarters:
Milford,Massachusetts,United States,North America
Founded Date:
1905-01-01
